Tenax Therapeutics (TENX) Raw Materials (2012 - 2014)
Tenax Therapeutics (TENX) posted quarterly Raw Materials of $28779.0 for Q1 2014, little changed year-over-year from $28779.0 in Q1 2013, and little changed on a QoQ basis from $28779.0 in Q4 2013.
Tenax Therapeutics (TENX) Raw Materials (2012 - 2014) Analysis & Trends
Tenax Therapeutics has reported Raw Materials for 3 years, with the latest figure at $28779.0 in Q1 2014.
- Raw Materials for Q1 2014 came in at $28779.0, changed 0.0% year-over-year; the trailing twelve-month figure through Jan 2014 was $28779.0 (changed 0.0% YoY), and the FY2013 annual result was $28779.0, up 12.51% from the prior year.
- Raw Materials held at $28779.0 in Q1 2014, from $28779.0 in the prior quarter.
- Over five years, Raw Materials peaked at $38147.0 in Q3 2012 and troughed at $25579.0 in Q2 2012.
- A 3-year average of $29550.0 and a median of $28779.0 in 2012 frame the typical range for Raw Materials.
- The largest YoY upside for Raw Materials was 12.51% in 2013 against a maximum downside of 24.56% in 2013.
- A 3-year view of Raw Materials shows it stood at $28779.0 in 2012, then changed by 0.0% to $28779.0 in 2013, then changed by 0.0% to $28779.0 in 2014.
- Per Business Quant data, the three most recent Raw Materials figures were $28779.0 in Q1 2014, $28779.0 in Q4 2013, and $28779.0 in Q3 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2014 | 28,779.00 |
| Oct 31, 2013 | 28,779.00 |
| Jul 31, 2013 | 28,779.00 |
| Apr 30, 2013 | 28,779.00 |
| Jan 31, 2013 | 28,779.00 |
| Oct 31, 2012 | 28,779.00 |
| Jul 31, 2012 | 38,147.00 |
| Apr 30, 2012 | 25,579.00 |